Thankful

Like most of you, I feel like I am living in a washing machine — tumbling, twisting, hit by unexpected items as the many events of the day, some of them ominous, swirl about. However, I have much to be thankful for as we head into Thanksgiving week.

Read more.



Georgetown Lombardi Members: Please Complete the Shared Resource User Survey

All Georgetown Lombardi members should complete the Shared Resource User Survey by Friday, December 1. Information gathered as part of this process provides data critical to planning and decision-making processes, particularly as it relates to members’ needs for Shared Resource services in D.C. and Hackensack. Results will be available to members in early 2024. Contact Sharon Levy (sgl5@georgetown.edu) or David Goerlitz (dsg3@georgetown.edu) with questions. Access the survey here.

Global Oncology Newsletter Now Available

The new Office of Global Oncology released its first newsletter, which highlights the results of its survey on global oncology efforts, upcoming events, and activities the office expects to put in motion in 2024. For more information about the office and its work, contact cal9@georgetown.edu. Read the full newsletter.

Foundational Principles for Equity in Assessment in Health Professions Education

Tuesday, November 21

12:00 - 1:15 p.m.

Mun Chun Chan, PhD, associate teaching professor, Department of Biology, and STEM pedagogy specialist, CNDLS, presents this workshop for fellows, residents and staff that provides a foundational framework and tools for designing and redesigning assessments as part of a more equitable and inclusive course in the health profession fields. Part of the Equity Forward Faculty Workshops series. RSVP for this Zoom workshop.

Department of Microbiology & Immunology Seminar Series: “CpG and Therapeutic Vaccines”

Tuesday, November 21

12:15 - 1:15 p.m.

Presented by Joseph A. Bellanti, MD, professor of pediatrics and microbiology-immunology (Emeritus), director, International Center for Interdisciplinary Studies of Immunology (ICISI), GUMC. Join this seminar in Med-Dent NE301 and via Zoom.

NEXT WEEK: Strategies for Equity in Assessment in Narrative Comments

Tuesday, November 28

5:15 - 6:30 p.m.

Carrie Chen, MD, PhD, senior associate dean for assessment and educational scholarship, professor of pediatrics with Georgetown University School of Medicine leads this workshop that will review common biases found in narrative comments and recommended strategies for combating these biases. Part of the Equity Forward Faculty Workshops series. RSVP for this Zoom workshop.

14th Biennial Thyroid Update 2023: New Concepts in the Diagnosis and Treatment of Thyroid Disease

Friday, December 1

8:00 a.m. - 4:45 p.m.

This in-person event, held at the Bethesda Marriott in Bethesda, MD, is for all health care professionals with an interest in patients with thyroid disorders. It provides updates on thyroid conditions, including thyroid cancers; addresses current and controversial issues in thyroid disease; and familiarizes providers with key elements of updated guidelines and how to incorporate them into a clinical practice. Register for this event.

Ten-Year Update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 Randomized Trial: Extended Letrozole Therapy in Early-Stage Breast Cancer

Using Simulation Modeling to Guide Policy to reduce Disparities and Achieve Equity in Cancer Outcomes: State of the Science and a Road Map for the Future

Opportunities, Challenges, and Future Directions for Simulation Modeling the Effects of Structural Racism on Cancer Mortality in the United States: A Scoping Review

Population Simulation Modeling of Disparities in US Breast Cancer Mortality

A Health Equity Framework to Support the Next Generation of Cancer Population Simulation Models

Overcoming the Hurdles: Surmounting Acquired Resistance to Anti-EGFR Therapy in Metastatic Colorectal Cancer

Surgical Resection Criteria and Neoadjuvant Therapies for Intrahepatic Cholangiocarcinoma

Loss of Cadherin-11 in Pancreatic Ductal Adenocarcinoma Alters Tumor-Immune Microenvironment

Modeling the Future of Tobacco Control: Using SimSmoke to Explore the Feasibility of the Tobacco Endgame in Korea

Heparan-6- O-Endosulfatase 2 Promotes Invasiveness of Head and Neck Squamous Carcinoma Cell Lines in Co-Cultures with Cancer-Associated Fibroblasts

Integrating Embeddings from Multiple Protein Language Models to Improve Protein O-GlcNAc Site Prediction

Multi-omic Profiling Reveals Discrepant Immunogenic Properties and a Unique Tumor Microenvironment Among Melanoma Brain Metastases

Associations Between Diet Quality and Proinflammatory Cytokines in Newly Diagnosed Head and Neck Cancer Survivors



Moderating Influences on Parents' Fatalistic Beliefs About Cancer and Their Association With Sun Safety Behaviors Among Children of Melanoma Survivors: Implications for Treatment

OncLive New Data From 2023 ESMO Congress Further Define the Evolving Role of ADCs in NSCLC

OncLive FDA Approval of Fruquintinib Expands Later-Line Treatment Options in mCRC

OncLive Interim Management Strategies Could Aid Patients With Advanced NSCLC Awaiting Biomarker Test Results

AACR Clinical Oncology Research (CORE) Training Fellowships Program

The AACR Clinical Oncology Research (CORE) Training Fellowships Program is designed for early career clinical scientists who hold a medical degree (MD, DO, or MD/PhD) and are interested in acquiring the knowledge and skills related to clinical trial design and execution from the perspective of the pharmaceutical industry. Each fellowship provides $100,000 over one year for the fellow to work on site at the facility of one of the AACR’s pharmaceutical industry partners. Application deadline: 5:00 p.m. on Thursday, November 30. View more information, including eligibility requirements, program guidelines and application instructions.

Cancer Research Institute Clinic and Laboratory Integration Program Grants

The Cancer Research Institute offers Clinic and Laboratory Integration Program (CLIP) grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. These grants support preclinical and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic. Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. Funding: up to $150,000 per year for two years. LOI deadline: Friday, December 1. Full application deadline: March 1, 2024. View more information and application guidelines.

Damon Runyon Quantitative Biology Fellowship Award

The Damon Runyon Quantitative Biology Fellowship Award supports computational scientists who are deeply connected to biology labs so that they can bring their computational skills to bear on important biological questions, particularly in cancer. The proposed mentored research training must reflect the individual's potential to develop into a productive, independent cancer research scientist. (Note: Applicants must not have been in their mentors’ labs for more than 24 months prior to the application deadline date.) The award provides up to $240,000 over three years in stipend and expense allowances for the award recipient. Application deadline: 4:00 p.m. on Friday, December 1. View more details and application guidelines.

Damon Runyon Physician-Scientist Training Award

In an effort to confront the growing dearth of physician-scientists, the Damon Runyon Cancer Research Foundation has created this award program, which is designed to recruit outstanding U.S. Specialty Board-eligible physicians (MD/DOs only) into cancer research careers by providing them with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed all of their clinical training. The award will provide up to $460,000 over four years in financial support for the award recipient. In addition, the Foundation will retire up to $100,000 of medical school debt still owed. Application deadline: 4:00 p.m. on Friday, December 1. View more information and application guidelines.

Mary Kay Ash Foundation Innovative/Translational Cancer Research Grant

The Mary Kay Ash Foundation, a funding source for cancer research, is currently accepting applications for innovative grants for translational research for cancers affecting women, including but not limited to ovarian, uterine, breast and/or cervical cancer. Principal Investigator must be appointed a full-time assistant professor or higher at the time of application submission and commit a minimum 5% effort. Grants will be awarded in the amount of $100,000 over a two-year period. View more information. Please submit grant documentation to Sharon Levy (sgl5@georgetown.edu) by Friday, Jan. 19, 2024.

8:00 AM | Division Weekly Update Meeting | Podium A / Microsoft Teams

8:30 AM | Monday Morning Oncology Report | Inpatient Oncology Fellow | Podium A / Microsoft Teams

9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528 212 194)

11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796 253 566)

4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869 742 463)

9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)

4:00 PM | Liver Tumor Board | Microsoft Teams

5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 937 7707 3374; CME code: 80044)

8:00 AM | Thoracic Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 993 7680 5192; Passcode: 4231; CME 86693)

12:00 PM | Melanoma Tumor Board | Podium A / Microsoft Teams (CME: 80988)

5:00 PM | GI Tumor Board | Podium A / Microsoft Teams

9:00 AM | Cancer Research Data Meeting - None | W302 New Research Building or Zoom

9:30 AM | Head and Neck Tumor Board | Microsoft Teams

12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)

5:00 PM | Lymphoma Tumor Board - every other week | Microsoft Teams

5:00 PM | Myeloma Tumor Board - every other week | Microsoft Teams

7:00 AM | CNS Tumor Board | Microsoft Teams (Meeting ID: 298 285 483 265, Passcode: rJWpmU)

12:00 PM | Oncology Grand Rounds Lecture Series | None | New Research Building Auditorium / Zoom

12:00 PM | No Conference - Thanksgiving | Podium A | Teams Conference Link (Text In Code: 81202 or 81203 / Text In Telephone: 202-796-7323)

1:00 PM | No Conference - Thanksgiving | Podium A | Teams Conference Link (Text In Code: 81202 or 81203 / Text In Telephone: 202-796-7323)

1:00 PM | Pancreas Tumor Board | Microsoft Teams (Meeting ID: 299 996 740 910, Passcode: z7j7Rc)

2:00 PM | No Conference - Thanksgiving | Podium A | Teams Conference Link (Text In Code: 81202 or 81203 / Text In Telephone: 202-796-7323)